Protein Kinase C-θ Knockout Decreases Serum IL-10 Levels and Inhibits Insulin Secretion from Islet Β Cells

Feng Hong,Yang,Baiyi Chen,Peng Li,Guoguang Wang,Yuxin Jiang
DOI: https://doi.org/10.1080/19382014.2021.1890963
2021-01-01
Islets
Abstract:Various subtypes of protein kinase C (PKC) are expressed in islet beta cells and regulate beta cell proliferation and survival. PKC-theta is distributed in the immune system and promotes the secretion of IL-10, which manifests a critical role in the onset of diabetes, by the immune cells. However, the role of PKC-theta in islets has not been concerned. In the present study, we investigated the role of PKC-theta in the protection of islet beta cells and insulin secretion. Fasting glucose and insulin measurement, glucose tolerant test, immunofluorescence, and ELISA were conducted to study the influence of PKC-theta knockout on islet beta cell survival and function, and explore the mechanism underlying this regulation. PKC-theta knockout mice at 2 weeks manifested normal serum insulin levels, glucose tolerance, and beta cell mass. Knockout mice at 8 weeks show decreased beta cell mass, but manifested normal insulin levels and glucose tolerance. Knockout mice at 16 weeks manifested impaired glucose tolerance, beta cell mass, and decreased glucose stimulated insulin secretion. Furthermore, knockout mice manifested decreased serum IL-10 level compared with normal mice since 2 weeks. IL-10 injection into knockout mice improved glucose tolerance, serum insulin level, and reduced beta cell mass, and IL-10 administration into cultured pancreatic tissue increased glucose stimulated insulin secretion. PKC-theta knockout decreases the secretion of IL-10, reduces beta cell mass and insulin secretion in pancreatic islets. The present study illuminates the critical role of PKC-theta in protecting the survival and function of islet beta cells.
What problem does this paper attempt to address?